Therapeutic options for PD-1 refractory skin cancer 3 Jan – 6PM BST | 1PM EDT | 10AM PDT Allison Betof Warner, Omid Hamid, Inderjit Mehmi Join this VJSessions panel discussion with Allison Betof-Warner (Stanford), Omid Hamid (Angeles Clinic), and Inderjit Mehmi (Cedars-Sinai) which focuses on advances in treating PD-1 refractory melanoma. Topics discussed include therapeutic options, including combination checkpoint blockade strategies, TIL therapy, and oncolytic viruses, as well as the importance of early intervention and personalized treatment approaches to improve patient outcomes.